Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001164 · ClinicalTrials.gov registry record
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
NCT00001164: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001164 is a clinical trial that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001164 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
Study Summary
It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1978-07 |
| Est. Completion | 2000-06 |
What the finished NCT00001164 record still lists
NCT00001164 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00001164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001164 about?
NCT00001164 is a clinical study titled "Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers". It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of ...
What is the current status of trial NCT00001164?
This trial is currently completed. The study started on 1978-07. Estimated completion is 2000-06.
Who is sponsoring clinical trial NCT00001164?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia